U3 Pharma Ag's Acquisition

U3 Pharma Ag was acquired by Daiichi Sankyo on May 21, 2008.

U3 Pharma AG is involved in targeted cancer drug development. The Company is advancing a portfolio of novel antibody-based therapeutics that will be used as mono therapies and combination therapies fo…

Articles about U3 Pharma Ag's Acquisition: